Keeping Comanche 2 open will help protect consumers from huge price spikes during time that another troubled Pueblo unit closed for repairs ...
Roche has staked a claim to use its oral selective oestrogen receptor degrader (SERD) giredestrant as a second-line therapy for breast cancer, regardless of a patient's ESR1 mutation status. Top-line ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback